ABSTRACT Affecting 1-3% of the population, mental retardation (MR) poses significant challenges for clinicians and scientists. Understanding the biology of MR is complicated by the extraordinary heterogeneity of genetic MR disorders. Detailed analyses of Ͼ1000 Online Mendelian Inheritance in Man (OMIM) database entries and literature searches through September 2003 revealed 282 molecularly identified MR genes. We estimate that hundreds more MR genes remain to be identified. A novel test, in which we distributed unmapped MR disorders proportionately across the autosomes, failed to eliminate the well-known X-chromosome overrepresentation of MR genes and candidate genes. This evidence argues against ascertainment bias as the main cause of the skewed distribution. On the basis of a synthesis of clinical and laboratory data, we developed a biological functions classification scheme for MR genes. Metabolic pathways, signaling pathways, and transcription are the most common functions, but numerous other aspects of neuronal and glial biology are controlled by MR genes as well. Using protein sequence and domainorganization comparisons, we found a striking conservation of MR genes and genetic pathways across the ‫007ف‬ million years that separate Homo sapiens and Drosophila melanogaster. Eighty-seven percent have one or more fruit fly homologs and 76% have at least one candidate functional ortholog. We propose that D. melanogaster can be used in a systematic manner to study MR and possibly to develop bioassays for therapeutic drug discovery. We selected 42 Drosophila orthologs as most likely to reveal molecular and cellular mechanisms of nervous system development or plasticity relevant to MR. Isolated MR with no other consistent defining features MR due to congenital hypothyroidism is now largely is known as nonspecific or nonsyndromal MR. To date, preventable through screening and hormone replaceall but one of these (Molinari et al. 2002) are X-linked, ment (Gruters et al. 2002) . Aside from this, the only but other autosomal genes may have eluded identificamolecular-based therapeutic approaches are dietary retion because of the considerably greater difficulty of strictions and supplements for inborn errors of metabomapping disorders to autosomal loci. 
M ENTAL RETARDATION (MR) is a common form
clinical conditions affect such large numbers of children of cognitive impairment affecting between 1 and and young adults and yet have no effective pharmacolog-3% of the population of industrialized countries (Roeleical therapy. One reason for the lack of drug treatments veld et Aicardi 1998) . Although there is deis the limited understanding of the molecular and cellubate over the definition and classification of MR (Leolar bases for MR. nard and Wen 2002), it is often defined by an IQ of Many environmental and genetic factors can cause Ͻ70, with deficits in adaptive skills included as diagnos-MR, including premature birth, prenatal infections, tic criteria (Luckasson et al. 1992; Daily et al. 2000) .
chromosomal abnormalities, and single-gene mutations Behavioral and cognitive therapies can help mentally (Kinsbourne and Graf 2000) . An etiology can be estabretarded patients reach their maximum potential (Batlished in 60-75% of cases of severe MR, but only in haee Butler et al. 2001) , but they are not curative 38-55% of mild cases. Estimates of genetic causes of and often focus on treating habit disorders, aggression, severe MR range from 25 to 50% (McLaren and Bryor self-injurious behavior that can accompany MR son 1987). There are two categories of hereditary MR. (Long and Miltenberger 1998; Dosen and Day 2001) .
Isolated MR with no other consistent defining features MR due to congenital hypothyroidism is now largely is known as nonspecific or nonsyndromal MR. To date, preventable through screening and hormone replaceall but one of these (Molinari et al. 2002) are X-linked, ment (Gruters et al. 2002) . Aside from this, the only but other autosomal genes may have eluded identificamolecular-based therapeutic approaches are dietary retion because of the considerably greater difficulty of strictions and supplements for inborn errors of metabomapping disorders to autosomal loci. MR also occurs, lism such as phenylketonuria (Dashman and said to cause MR (see Stevenson et al. 2000) , even (Apweiler et al. 2001; http:/ /www.ebi.ac.uk/interpro/scan. when the onset is in late childhood or adolescence (e.g., (Hammer et al. 2002) . For the purpose of our analysis on Drosophila genes. Newly isolated P-element insertions were of hereditary MR, we chose a broader, albeit less precise, found through the P-Screen Database (http:/ /flypush.imgen.
definition that includes progressive disorders with onset bcm.tmc.edu/pscreen/).
Identifying human mental retardation genes through
of cognitive impairment in childhood and, occasionally,
OMIM:
We searched all OMIM fields on February 21, 2002, as late as adolescence.
using the phrase "mental retardation" and reviewed each of
In parallel with human genetics research, progress in the resulting 1010 entries. To include very mild MR, we also Drosophila melanogaster genetics and genome sequencing searched for "cognitive impairment" and "learning disability," (Adams et al. 2000) allows a comparative approach to obtaining 38 additional entries for evaluation. In retrospect, "developmental delay" and "psychomotor retardation" would the biological study of MR. Not only do homologous have been useful search phrases as well. Other MR genes were mammalian and fruit fly genes share biological funcidentified by periodic literature searches through September tions (Padgett et al. 1993; Bonini et al. 1997; Johnston 30, 2003 , using NCBI's PubMed. et al. 1997 Leuzinger et al. 1998; Nagao et al. 1998;  Careful evaluation of individual OMIM search results and Dearborn et al. 2002) , but also Drosophila provides cross-referencing with literature-search results revealed both false positives and false negatives. OMIM contains many paruseful models of human disease, including spinoceretially redundant entries, which makes it impossible to equate bellar ataxia (Warrick et al. 1998) dozen of these genes are most likely to have mutant (spastic paraplegia 1). There is a separate OMIM entry for each of these disorders and a fourth entry for the L1CAM phenotypes due to primary developmental defects of gene. There is some text redundancy among the four entries, neurons or glia and thereby provide clues to the causes but only the L1CAM entry includes the allelic variants field.
and treatment of MR due to single-gene mutations.
On the basis of this organizational scheme, OMIM searches Treatment strategies based on the understanding of restricted to entries containing the allelic variants field should eliminate redundant results. However, this strategy would hereditary MR may be useful for acquired MR as well.
cause false negatives because entries that list allelic variants Identifying Drosophila orthologs of human mental retardation genes: We used bioinformatics tools to determine if the do not necessarily contain complete phenotype descriptions. For example, entry 600514, which lists the allelic variants of human MR genes have likely functional orthologs in D. melanogaster. For MR genes encoding tRNAs, we aligned the human reelin (RELN ), does not contain the phrase "mental retardation," whereas entry 257320 for Norman-Roberts type lisand fly tRNA homologs using LALIGN and calculated the percentage identity. For each protein-coding MR gene, we sencephaly syndrome due to RELN mutations contains the search phrase but does not list allelic variants. In principle, searched the D. melanogaster sequences of the NCBI nonredundant database with NCBI's BLASTP. We used an E -value cutoff the "clinical synopsis" field could offer a useful search strategy for disease phenotypes, but some are incomplete (e.g., the of 1 ϫ 10 Ϫ10 (1e -10), a threshold commonly used for humanclinical synopsis for Norman-Roberts lissencephaly does not fly gene comparisons (Fortini et al. 2000; Lloyd et al. 2000 ; include MR although it is a consistent phenotype of this disorReiter et al. 2001) . The Homophila database (Reiter et al. der) and many entries have no clinical synopsis at all.
2001) is designed for such comparisons but, due to its organiErrors in the clinical synopsis fields also contributed to zational features and infrequent updates, we found it easier the many ‫)%51ف(‬ false-positive entries (see Table 1 ). For and more reliable to do our own BLAST searches. For one example, entries 167200 and 167210 for pachyonychia con-MR gene, we concluded that Drosophila does not have a genita types 1 and 2 include MR in their clinical synopses, biologically meaningful homolog despite a published claim but the only evidence for MR is in the much rarer type 4 of one. Grunge (FBgn0010825) is the most similar fly gene (Feinstein et al. 1988) . Other false positives result from stateto human DRPLA (Zhang et al. 2002) , but has a BLASTP ments such as "neither [patient] had evidence of mental retar-E -value of 5E-2, which does not meet our threshold. Moreover, dation" (entry 243605). In other entries MR is not a feature sequence similarity is limited to the extreme C terminus and of the disorder being described, but some atypical patients the Grunge protein does not possess the same domain organiare mentally retarded due to deletion of adjacent genes (e.g., zation as DRPLA. entry 312865). Finally, MR may be mentioned because related For protein-coding MR genes, we also conducted a "reverse" disorders have a MR phenotype. For instance, MR is a pheno-BLASTP search using the top-scoring Drosophila BLASTP retype of a subset of hereditary spastic paraplegias, so it is mensult as a query against the human sequences of the NCBI tioned in the text of the entries for most forms. Boyadjiev and nonredundant database. A Drosophila gene was considered Jabs (2000) noted similar difficulties in extracting information an ortholog of a human MR gene only if this reverse analysis from OMIM. To obtain complete information from OMIM, (sometimes supplemented with dot-matrix plot and proteinone must search in a manner that yields redundant and irreledomain comparison; see below) revealed that it was more vant entries. This minimizes false negatives, but, to interpret similar to the human MR gene (or a paralog) than to another the search results accurately, one must be willing to review gene. For example, the Drosophila proteins most similar to individual entries carefully. Even using a broad OMIM search human glial fibrillary acidic protein (GFAP) are the products strategy, we missed 45 MR genes that were revealed through of Lamin and Lamin C. A reverse BLASTP search revealed various literature search strategies.
that, although these two proteins share a single common doFunctional classification of human mental retardation genes:
main with GFAP, they are more similar over their full lengths We searched for the 282 MR gene products in the molecularto members of the human lamin family. In addition, both function category of the GO database and used information human and Drosophila lamins are localized to the nucleus from the literature to classify those not yet in the database. (Goldman et al. 2002) , whereas GFAP is cytoplasmic (Eng et al. The GO database is composed of three parallel schemes for 2000) . Hence, GFAP does not have an ortholog in Drosophila. classifying gene function: biological process, cellular compoWhen compared with mammals, Drosophila has relatively nent, and molecular function (Gene Ontology Consortium few duplicated genes (Durand 2003) , so in some cases a 2001). Each ontology is a hierarchical classification scheme Drosophila gene is the single ortholog of a paralogous set of (directed acyclic graph) of structured vocabulary terms that human genes. For example, FMR1, which causes fragile X differs from a simple hierarchical tree, such as a pedigree, in syndrome, is a member of a gene family that also includes FXR1 that each term may be a "child" of multiple independent and FXR2, the autosomal fragile X-related genes. Drosophila "parents." There are 24 occupied top-level terms in the molecdfmr1 is the only homologous fly gene, sharing significant ular-function ontology, i.e., terms that do not have parents sequence similarity and domain structure with all three human themselves. When GO assigned gene products to multiple genes, suggesting that it is the sole ortholog. molecular functions, we chose the most specific term for each.
To determine if orthologous genes are likely to share the For example, we classified the ␣-subunit of Gs, the adenylsame molecular and biological functions in humans and flies, ate cyclase-stimulating guanine nucleotide-binding protein we used dot matrix plots (GCG DotPlot) to assess the extent (GNAS), as a "nucleotide-binding protein" rather than as a of protein sequence similarity and searched the InterPro data-"hydrolase," the other GO assignment. For genes considered base for known functional domains in each protein. GCG by GO to have "unknown function," we found that most could TransMem was used to predict transmembrane regions in be provisionally classified on the basis of data in the literature. the human and fly proteins. If the proteins share sequence The "biological function(s)" assignments were based on similarity over most of their lengths and have similar organizaliterature reviews for each gene, including neuroimaging, tion of known functional domains, we considered them to be gene expression, and neuropathological data from human candidate functional orthologs. In some cases we also considpatients, as well as studies of wild-type and mutant mice. We ered expression patterns, mutant phenotypes, and subcellular first designated the basic cellular process in which the gene is localization. In cases of "computed genes" predicted from the primarily involved, e.g., cytoskeleton or chromosome strucDrosophila genome sequence, the absence of experimental ture. We then identified the site of primary organ system funcdata made the evaluation of ortholog status more difficult. tion, relative to MR: endocrine system, central nervous system, or neither. For those genes that directly impact central nervous system (CNS) development and/or function, we ascertained RESULTS AND DISCUSSION the tissue type (neuron, glia, or blood vessel) and the specific cellular process affected (e.g., cell identity or differentiation).
The 282 mental retardation genes have been molecu-
We also considered whether MR caused by mutation of the gene is secondary to toxicity or secondary to energy or fuel deficiency.
larly identified: Analysis of OMIM and literature search Category 6: The disorder is caused by a gross chromocontain the search phrase "mental retardation." About somal abnormality and no single gene determines the a quarter of these "false-negative" entries contained the MR phenotype (Down syndrome is one example). phrases "psychomotor retardation" and/or "developCategory 7: MR is not a phenotype of the disorder. mental delay." To include disorders causing very mild Category 8: The disorder does not exist. MR, we also searched OMIM for entries containing "cognitive impairment" or "learning disability" but not "men-
The number of OMIM entries in category 1 ("known tal retardation." Most of these 38 entries describe adultgene"), 254, is greater than the number of genes, 204, onset, progressive cognitive impairment disorders, but because of OMIM database redundancy (see materials literature review identified 4 of them as MR genes. Fiand methods). The nearly 600 OMIM entries in categonally, literature searches between March 2002 and Sepries 2-5 represent MR disorders in which the causative tember 30, 2003 revealed 29 recently identified MR genes were unknown (see below). Of the 29 recently genes for a total of 282 human genes known to cause discovered MR genes, half had "advanced" from "candi-MR (Figure 1 ). On the basis of these and subsequent date gene" (1 gene), "chromosomal region" (9 genes), publications, we estimate that new MR genes are being or "unmapped" (5 genes) categories. Thirteen repreidentified at a rate of 1-2 per month. The appendix sent new loci that can cause a known disorder. One lists the 282 MR genes in alphabetical order by their (FKRP) causes a form of muscular dystrophy, not pregene symbols, along with their associated MR disorders, viously associated with MR, that had been in category 7. chromosomal locations, OMIM numbers, and other inEntries in category 6 ("chromosomal abnormality") formation explained below. As will be discussed in later describe bona fide MR disorders, but we have not considsections, the MR genes control an extraordinary range ered them further in this analysis because they appear of molecular and cellular functions.
to involve many genes (e.g., Shapiro 1999). It remains We classified the 1010 OMIM "mental retardation" to be determined whether individual genes that contribentries, based on data available in spring 2002, ac- ute to MR in cases of aneuploidy or other chromosomal cording to the following scheme (Table 1): defects can mutate to an MR phenotype individually. The 149 OMIM entries in category 7 ("no MR phenoCategory 1: The disorder has been mapped to a specific type") represent false positives in which MR is not a Fourth, mutations in genes controlling thyroid development or function rarely cause MR in industrialized phenotype (see materials and methods). Most of societies because of neonatal screening and treatment these false-positive errors could be eliminated by the for hypothyroidism (Gruters et al. 2002) . Hence, while adoption of a controlled vocabulary for OMIM clinical a dozen known genes have been associated with MR synopses, with the previously mentioned caveat that MR secondary to hypothyroidism (appendix), mutations in definitions vary. The three entries in category 8 ("nonother similar genes may not have had the "opportunity" existent disorders") do not represent distinct clinical to reveal whether they would cause MR in untreated entities, and one was subsequently removed from the patients. Finally, syndromal MR genes for which the MR OMIM database.
phenotype has very low penetrance present a significant With ‫006ف‬ OMIM MR entries in categories 2-5 (Taascertainment challenge. For example, eight DNA reble 1), it is obvious that many more MR genes remain to pair genes/disorders are associated with MR in a modest be identified-but how many? Some of these disorders, fraction of patients. It seems likely that more such disorparticularly those in categories 4 ("candidate chromoders (e.g., the rarer Fanconi anemia complementation some") and 5 ("not mapped"), are likely to represent groups) have MR as a bona fide phenotype, but, presum-MR genes that are already known. This is because of ably because the phenotype depends on chance somatic both practical difficulties in mapping human phenomutations during brain development (Gilmore et (Table 2) , the distinction between the two cate-X-linked MR syndromes for which the genes remain gories may not be as meaningful as originally proposed elusive. However, only 80 OMIM entries described (see discussion in Frints et al. 2002) . X-linked MR disorders (syndromes and nonspecific) for For RSK2 (RPS6KA3), the phenotype difference is which genes have not been identified (Table 1 , X-linked explained by allele type and severity. The R383W muentries in categories 2-4).
tation that causes MRX19 is a partial loss-of-function A third "missing" or underrecognized category is comallele, encoding a protein with 20% of wild-type kinase posed of essential genes of which most deleterious mutaactivity (Merienne et al. 1999) . In contrast, null mutions cause early prenatal lethality and only exceptional tations of RSK2 cause Coffin-Lowry syndrome with alleles with specific molecular consequences permit viaprominent skeletal and connective tissue involvement bility along with an MR phenotype. In genetic model (Hanauer and Young 2002) . For several genes, the systems, complementation testing can easily show that a structure-function relationships are inferred but not diviable "memory mutation" is allelic to mutations causing rectly demonstrated. The T1621M mutation of ATRX early death with profound neuroanatomical defects (also known as XH2 or XNP) causes nonspecific MR (e.g., Pinto et al. 1999) , but comparable mapping studin the mild-to-moderate range (Yntema et al. 2002) . Although residue 1621 is within the highly conserved ies are much more difficult in humans. SNF2-related domain, it is not conserved, suggesting Chromosomal distribution of human mental retardation genes: Of the 282 human MR genes, 11 are encoded that some alterations at that site are compatible with partial function of this nuclear protein involved in chroby the mitochondrial genome. Figure 2A shows the chromosomal distribution of the 271 nuclear MR genes matin structure and transcription regulation. Missense mutations just 7 and 12 residues upstream, however, compared to the chromosomal distribution of all known and predicted human genes based on the human gecause a more severe, syndromal phenotype with hematologic, skeletal, and genital defects (Gibbons et al. 1995) , nome sequence (Venter et al. 2001) . While ‫%4ف‬ of known and predicted genes are on the X chromosome, suggesting greater disruption of ATRX function. A variety of FGD1 mutations, most of which truncate the en-‫%61ف‬ of the MR genes reside there-a fourfold overrepresentation. In contrast, the distribution of MR coded putative Rho GEF, cause Aarskog-Scott syndrome, which includes highly penetrant skeletal and genital genes among the autosomes roughly parallels their relative gene contents ( Figure 2A ). An even greater X-chroanomalies but infrequent, and only mild, MR. In contrast, one particular missense mutation in a region of mosome overrepresentation is found among the MR disorders mapped to candidate loci (6-fold), chromounknown function, P312L, causes severe, fully penetrant nonspecific MR (Lebel et al. 2002) .
somal regions (14-fold), and chromosomes (15-fold), which correspond to categories 2, 3, and 4, respectively, Genotype-phenotype relationships are even more complex for MECP2 and ARX. Within and among Rett of Table 1 . It has been proposed that the human X chromosome syndrome families, females with MECP2 mutations show great clinical heterogeneity, with X-inactivation patterns contains a disproportionately high density of genes for cognitive ability (Lehrke 1972 ; Turner and Partingand mutation sites believed to explain the severity differences (Cheadle et al. 2000; Hammer et al. 2002) . In ton 1991). This proposal generated controversy as well as speculation concerning possible underlying evolutionaddition, at least seven different missense mutations in MECP2, scattered over the length of the protein, cause ary mechanisms, including the intriguing suggestion that female mate selection for high male intelligence nonspecific MR (Orrico et al. 2000; Couvert et al. 2001) ; several of these are very close to sites of Retthelped accelerate the rapid rise of human cognitive abilities (Turner 1996; Zechner et al. 2001) . The identisyndrome-causing missense mutations (Cheadle et al. 2000; Hammer et al. 2002) . For ARX, identical mutafication of numerous MRX genes and X-linked MR syndromes (Chiurazzi et al. 2001) seemed to support the tions, resulting in polyalanine tract expansion of this homeodomain protein, caused nonspecific MR in one proposal. Opponents, however, argued that all X-linked recessive mutations are simply easier to map and identify family, but distinct neurological syndromes (West or Partington or MR with hypsarrhythmia) in various other because their phenotypes are revealed in hemizygous males (Morton 1992; Lubs 1999) . Countering this view families (Stromme et al. 2002) . This suggests a major effect of genetic background on ARX phenotypes. Other is an OMIM-based analysis (Zechner et al. 2001) showing a 7.2-fold X-chromosome bias for MR genes, whereas ARX mutations cause a unique lissencephaly syndrome with abnormal genitalia (Kitamura et al. 2002) .
genes causing common morphological phenotypes (polydactyly, cleft palate, facial dysplasia, skeletal dysplaComplex genotype-phenotype relationships are also a feature of some autosomal MR disorders (e.g., FGFR1, sia, and growth retardation) have, on average, only a 2.4-fold X-chromosome bias. [Zechner et al. (2001) did GLI3, PEX1, PTEN, PTPN11) . On the basis of X-linked MR, it is possible that some alleles of the one known not take OMIM errors, such as false positives and negatives, into consideration, but such errors may be compaautosomal nonspecific MR gene (PRSS12; Molinari et al. 2002) will be found to cause a syndromal MR phenorable across phenotypes.] To take this question one step further, we asked type. Conversely, autosomal genes presently known to cause MR syndromes may be able to mutate to a nonspewhether the apparent X-chromosome overrepresentation among the molecularly identified human MR genes cific MR phenotype. (Figure 2A ) would disappear if we accounted for the plausible possibility that numerous autosomal loci are "hiding" among the unmapped MR genes (represented by the OMIM entries in category 5, Table 1 ). We attempted to overcome the ascertainment bias that favors identification of X-linked genes by making simplifying assumptions that maximize the estimate of autosomal MR genes and minimize the estimate of X-linked MR genes. First, we assumed that one OMIM entry equals one gene. Second, for the unmapped MR disorders (category 5, Table 1), we assumed that each represents a different, novel autosomal gene and that these are distributed in proportion to the overall gene distribution on those chromosomes (Venter et al. 2001) . Third, for those disorders whose genes map to chromosomal regions and candidate chromosomes (categories 3 and 4, Table 1), we assumed that there will be no new X-linked genes, i.e., that each potential X-linked gene is identical to an X-linked gene already known to cause MR. However, all candidate genes (category 2, Table  1 ), including the X-linked genes, were assumed to be new MR genes.
Even when these very conservative (i.e., biased toward autosomal) assumptions are used to estimate the chromosomal distribution of the unknown MR genes, a 1.9-fold overrepresentation of MR genes on the X chromosome remains ( Figure 2B ). This result supports the hypothesis that the X chromosome contains a disproportionately high density of genes influencing cognitive ability. One caveat is the possibility discussed above that many autosomal MR genes may be so rare or difficult to study that they never appear in the medical literature and, hence, in OMIM. We also agree with the suggestion of Lubs (1999) that resolution of this issue would be enhanced by analyzing genome-wide brain expression data and by searching for allelic variation in single genes responsible for the high end of the intelligence spectrum.
D. melanogaster homologs of human mental retardation genes: We found that 87% of known MR genes (246/282) have at least one Drosophila homolog with a BLASTP E-value of 1 ϫ 10 Ϫ10 or better ( Figure 1 ; bers, and the BLASTP E-values (see also Figure 1 for the GO database (Figure 3 ; appendix; see materials and methods). The MR genes are distributed over a overview). As discussed below, several dozen Drosophila broad range of functions, indicating that disruption of orthologs (designated " ¶" in the appendix) are prime any of a wide array of molecular processes can impair candidates for cellular and molecular study of MR. Sevbrain function so as to cause MR. Several categories are enteen MR genes (6%; designated with asterisk) have prominently represented, such as enzymes (143 genes; one or more homolog(s) that may be orthologs, but it 51%), mediators of signal transduction (32 genes; 12%) is not possible to make a determination on the basis of and transcription regulation (19 genes; 7%), binding sequence analysis in the absence of experimental data.
proteins (23 genes; 8%), and transporters (21 genes; Another 16 MR genes (6%; in brackets) have one or 8%). Enzymes, especially those expressed in accessible more Drosophila homolog(s) that are not orthologs on peripheral tissues, make gene identification easier than the basis of reverse BLAST results or other sequence that for many other proteins, so their relative represenanalysis (see materials and methods). There are 36 tation may decline as new MR genes are discovered. MR genes (13%) with no Drosophila homolog, alOther categories with smaller numbers of MR genes though this number may decline as final gene identifiinclude cell adhesion molecule, structural molecule, cation for the Drosophila genome is completed.
motor protein, tRNAs, apoptosis regulator, chaperone, Some of the Drosophila genes are functional orand enzyme regulator. GO classifies ‫%9ف‬ of the MR thologs of human MR genes on the basis of experimengenes (25) in the "unknown function" category, but tal data. For instance, mutations of dfmr1, the Drosophpublished data suggest functions for all but 10 of them ila ortholog of fragile X mental retardation 1 (FMR1; Wan (see appendix). (e.g., binding activity, of which there are many subcateRestifo, unpublished results) and behavioral defects gories), as well as others related to a specific cellular (Dockendorff et al. 2002; Inoue et al. 2002) . Genetic process (e.g., cell adhesion molecule), and in many and biochemical data suggest that Drosophila dFMR1 cases, genes could be assigned to more than one. This is a regulator of translation (Zhang et al. 2001 ; Ishizuka makes classification, analysis, and comparison to other et al. 2002) , as has been shown for mammalian FMRP sets of genes somewhat difficult. We did not classify any ( . We also did not use the "translation regulator" data: G protein s␣60A (Connolly et al. 1996) , the orcategory, but EIF2AK3 encodes a kinase (our category tholog of GNAS; Neurofibromin 1 (Guo et al. 2000) , the choice) that indirectly regulates translation by phosortholog of NF1; cheerio (see Dubnau et al. 2003, online phorylating eukaryotic translation initiation factor-2 supplement), the ortholog of FLNA; and S6kII or igno- (Ma et al. 2002) . Similarly, we classified FMR1 as "RNA rant (G. Putz, T. Zars, and M. Heisenberg, personal binding," but considerable data demonstrate that it regcommunication), the ortholog of RSK2. Additional Droulates translation (Jin and Warren 2003) . In addition, sophila learning and memory genes have been prowe could have classified some genes in the "protein posed as candidates for MR disorders that are not yet stabilization" (e.g., PPGB), cytoskeletal regulator (e.g., mapped (Morley and Montgomery 2001) . TBCE), or "protein tagging" (e.g., UBE3A) categories. The Drosophila orthologs of the human MR genes However, anticoagulant, antifreeze, antioxidant, chapdo not have a skewed chromosomal distribution (Figure erone regulator, nutrient reservoir, and toxin are top-2C). Approximately 16% of all fly genes and 16% of level categories in which none of the 282 MR genes MR gene orthologs are on the X chromosome. Of the could be placed. first two dozen Drosophila "learning and memory Figure 3 indicates the Drosophila-homolog status of genes" identified, almost 50% are X-linked (reviewed in the MR genes in each molecular-function category. The Dubnau and Tully 1998; Morley and Montgomery 213 MR genes with Drosophila ortholog(s) (solid bars) 2001). However, the recent isolation of 60 new autoare distributed among the GO categories in roughly somal memory genes (Dubnau et al. 2003) indicates the same pattern as that of all the MR genes, with two that the older results reflect the previous tendency to exceptions. More than half of the "receptor binding" design X-chromosome screens for behavioral and genes (4 of 7) and 36% (9 of 25) of the "unknown neuroanatomical phenotypes.
function" MR genes have no Drosophila homolog.
Molecular functions of mental retardation genes:
Biological functions of mental retardation genes: We Each of the 282 MR genes was classified in a single devised a "biological function(s)" classification scheme for the 282 MR genes that considers both cellular-and molecular-function category, primarily on the basis of In cases where the top-level parent terms include large numbers of genes (signal transduction, binding, transcription regulation, enzyme), we show the distribution of genes among the children terms. For many of the genes that have not yet been classified by the GO Consortium, we used information from the literature to assign them to a GO term. For some of the genes designated "unknown function" by GO, we were able to assign provisional functions on the basis of published literature (see appendix), but these genes are included in the "unknown function" category of this figure. As indicated by the boxed legend, each bar indicates classification of the human MR genes based on the degree of similarity to Drosophila genes.
systems-level perspectives (Figure 4 ; appendix; see ma-
The major signaling pathways are represented among the MR genes, including those regulated by Sonic terials and methods). The basic cellular processes controlled by MR genes take place in the nucleus, in the Hedgehog (e.g., SHH), the TGF-␤ family of growth factors (e.g., GPC3), Notch (e.g., JAG1), and calcium (e.g., cytoplasm (including within organelles), and at the interface among cells, cell compartments, and the extra-ATP2A2). MR-related signaling cascades are mediated by diverse cell surface proteins, such as integrins (e.g., cellular milieu. In the nucleus, MR genes affect chromosome structure (e.g., DNMT3B), DNA repair (e.g., NBS1), ITGA7), G protein-coupled receptors (e.g., AGTR2), receptor tyrosine kinases (e.g., NTRK1), and intracellular basal and regulated transcription (e.g., ERCC2 and SIX3, respectively), as well as rRNA processing (e.g., DKC1).
proteins, including small G proteins (e.g., GDI1), heterotrimeric G proteins (e.g., GNAS), and phosphatidylinosiIn the cytoplasm, many MR genes have metabolic functions (see also Kahler and Fahey 2003) , involving tol (e.g., PTEN). Moreover, genes in a common pathway can share MR as a phenotype. SHH (Ming et al. 1998) , a wide range of pathways [citric acid cycle (e.g., FH), gluconeogenesis (e.g., GK), glycolysis (e.g., PDHA1), oxithrough its receptors encoded by PTCH and PTCH2, regulates GLI3, some of whose targets are also regulated dation (e.g., the PEX genes), oxidative phosphorylation (e.g., MTCO1), urea cycle (e.g., OTC), and general cell by GPC3. MR genes also control communication and transport integrity (e.g., GSS)] and biologically critical compounds [amine (e.g., MAOA), amino acid (e.g., OAT), across cell and organelle membranes. These include cation-chloride cotransporters (SLC12A1, SLC12A6) carbohydrate (e.g., GALE), cholesterol (e.g., SC5DL), creatine (e.g., GATM), fatty acid (e.g., ALDH3A2), heme that may be critical for inhibitory neurotransmission (Payne et al. 2003) . The transmembrane linkage (ITGA7, (e.g., PPOX), lipid (e.g., DIA), methionine (e.g., MAT1A), purine (e.g., HPRT), pyrimidine (e.g., DPYD), TM4SF2) between the extracellular matrix (LAMA2) and the cytoskeleton is strongly implicated in MR, as is cell and cofactors (e.g., TC2)]. MR genes involved in macromolecular synthesis and modification include those readhesion (L1CAM). The overlap between MR and muscle disease is strikquired for mitochondrial translation (e.g., MTTK), translation regulation (e.g., FMR1), protein folding (e.g., ing and appears to arise from at least three distinct mechanisms: reduced membrane/cytoskeletal stability BBS6), protein stability (e.g., PPGB), protein glycosylation (e.g., PPM2), and lipid synthesis (FACL4). Macro-(DMD, ITGA7, LAMA2); glycosylation defects associated with abnormal neuronal migration (FCMD, FKRP, molecular degradation in lysosomal (e.g., HEXA) and proteasomal (e.g., UBE3A) pathways is also commonly LARGE, POMGNT1, POMT1); and mitochondrial dysfunction (MTCO3 and many others). The biological disrupted by mutations in MR genes. MR genes have major effects on the cytoskeleton, including its actin basis of myotonic dystrophy (DM1) is unknown.
An integrative view of MR biology:
The hereditary (e.g., FLNA), microtubule (e.g., DCX), and intermediate filament (e.g., GFAP) components.
MR disorders can be approached from two somewhat independent perspectives: (i) where the genes are expancreas to regulate ATP-dependent, exocytotic insulin secretion. Mutations in either gene cause excess insupressed and function and (ii) the relationship between the mutation and pathogenesis of the MR phenotype.
lin release and hypoglycemia which, if inadequately treated, disrupts brain development and function due Genes may act selectively within the brain ("intrinsic or selective function") or primarily outside the CNS to systemic fuel deficiency (Vannucci and Vannucci 2001; Huopio et al. 2002) . Similarly, the brain's energy ("extrinsic or generalized function"). MR may result from fundamental cellular defects that impair many requirements make it very sensitive to genetic disruptions of mitochondrial function (Chow and Thorburn tissues ("generic effect"), with the brain sometimes having a higher sensitivity, or MR can result from selective 2000) . Mutations in mitochondrial genes (MTATP6, MTCO1, MTCO2, MTCO3, MTCYB, MTTE, MTTK, impairment of unique features of brain development or physiology ("selective effect"). With the caveat that MTTL1, MTTS1) or in nuclear genes encoding mitochondrial proteins (BCS1L, SCO2, SURF1, TIMM8A) MR pathogenesis is incompletely understood and that spatial expression data are limited, we consider examcause MR due to local energy (ATP) deficiency in neurons and glia (Servidei 2001) . ples of MR genes in these major categories.
Extrinsic or generalized function/generic effect: ABCC8 Extrinsic or generalized function/selective effect: In the endocrine system, locally synthesized hormones enter the (SUR1) and KCNJ11 gene products work together in the circulation and affect distant organs. MR genes include aly ("smooth brain") due to mutations in LIS1, DCX, and RELN, as well as ARX (some alleles) and FLNA several tissue-specific regulators of thyroid gland development (TTF2, PAX8) or thyroid hormone synthesis (Olson and Walsh 2002) . Agenesis (partial or complete) and dysgenesis of the interhemispheric corpus (DUOX2, TG, TPO; Kopp 2002 (Johnson 2002) . In contrast, key enzyme in lysine metabolism (Sacksteder et al. 2000) . In patients lacking AASS function, lysine accumu-PLP1 is expressed solely in oligodendrocytes and encodes the most abundant CNS myelin protein. Myelin lates and inhibits arginase, causing excess circulating ammonia, which interferes with neuronal and glial funcintegrity is very sensitive to PLP1 gene dosage, with duplications, deletions, and missense mutations all caustions (Felipo and Butterworth 2002) . Similarly, PAH is expressed mainly in nonneural tissues (Lichtering Pelizaeus-Merzbacher disease (Koeppen and Robitaille 2002) . Konecki et al. 1999) , with mutations causing elevated circulating phenylalanine. This systemic toxin impairs
At the other end of the spectrum are the many hereditary MR disorders for which routine neuropathological myelination, synaptogenesis (Bauman and Kemper 1982; Huttenlocher 2000) , and possibly aminergic data are unavailable or fail to show consistent defects. Higher-resolution Golgi staining has revealed dendritic neurotransmission (Surtees and Blau 2000) . The lysosomal storage disorders, which cause macromolecules abnormalities of cortical neurons in fragile-X (FMR1; Irwin et al. 2000) and Rett syndromes (MECP2; Armto accumulate in many tissues, may also belong to this category. Most represent degradative enzyme deficienstrong 2001) and possibly in Rubinstein-Taybi syndrome (CREBBP; Kaufmann and Moser 2000). All cies, but some of the genes encode transport, stabilizer, or activator proteins (Wisniewski et al. 2001) . They are three likely result from misregulated gene expression in the brain, but which target genes are responsible for classified by the compounds that accumulate in lysosomes, such as sphingolipidoses (e.g., ARSA), neuronal the dendritic defects remain to be determined. For MR disorders with no known anatomical lesions, ceroid lipofuscinoses (e.g., CLN1), glyoproteinoses (e.g., PPGB), and mucolipidoses (e.g., NEU1). The traditional such as nonsyndromal MRX, gene function in the CNS is inferred from molecular analyses. For example, GDI1 view that the progressive brain phenotypes result "simply" from local toxicity is countered by reports of specific (MRX41, MRX48; Bienvenu et al. 1998 ) encodes a brain-specific regulator of Rab-type G proteins. One of neurodevelopmental defects (Walkley 1998; Altarescu et al. 2002) .
its targets is believed to be Rab3A, which controls activity-dependent synaptic vesicle recruitment to axon terIntrinsic function/selective effect: For genes with selective expression or function within the CNS, the conseminals (Leenders et al. 2001) . Given the structure-function relationships underlying developmental synaptic quences of mutations are also primarily CNS selective, with variation in cell-type involvement and severity plasticity (Cohen-Cory 2002) , it seems likely that neuroanatomical phenotypes for this and other MRX disor- (Pomeroy and Kim 2000) . The coexistence of neuropathology and cognitive deficits supports the view of ders will eventually be found. Regardless of the scheme used, many disorders defy MR as a disorder of brain development or plasticity. At one end of the spectrum are MR disorders with gross straightforward classification. For example, the role of homocysteine in CNS development and function brain malformations. Holoprosencephaly, a failure of the right and left brain halves to form distinct hemi- (Mattson and Shea 2003) belies the "metabolic" classification of the MR genes CBS, MTHFR, MTR, MTRR, spheres, results from mutations in genes controlling cellular identity of forebrain neuronal precursors and TC2. The MR genes SC5DL and DHCR7 encode enzymes in cholesterol biosynthesis, making them also (PTCH, SHH, SIX3, TDGF1, TGIF, ZIC2; Wallis and Muenke 2000) . Schizencephaly ("cleft brain") is due to primarily "metabolic." However, because Sonic Hedgehog protein function is absolutely dependent on covadominant missense mutations in EMX2, which encodes a homeodomain-containing transcription factor (Faiella lent linkage to cholesterol (Ingham and McMahon 2001) , the enzymatic deficiencies may impair SHH siget al. 1997) . Abnormal neuronal migration in the rostral forebrain (the region of EMX2 expression) causes gross naling. It may be that, with sufficient research on molecular and cellular pathogenesis, few if any MR genes will morphogenetic as well as more subtle lamination defects. Neuronal migration defects also cause lissencephbe considered "just metabolic." Additional disorders may be caused by mutation of these genes; see the appendix.
c Based on neuropathology, neurophysiology, and/or brain imaging of human patients. In some cases, data from mouse mutants were also considered. Biological functions in brackets are inferred from molecular data (including gene expression and biochemistry) or sequence homology to proteins of known function.
All others are based on mutant phenotypes.
The role of D. melanogaster in MR research: In terms a ligand of Notch (the Drosophila ligand is Serrate). The biological relevance of genetic interactions in huof primary amino acid sequence and protein-domain organization, the degree of MR gene conservation between man MR is well demonstrated by some of the BardetBiedl syndromes (BBS2 and BBS6; see appendix) in humans and Drosophila is remarkable (Figure 1 ; appendix). Not only individual genes but also whole pathways which clinical manifestations result from "triallelic inheritance," homozygosity at one locus and heterozygoshave been retained through ‫007ف‬ million years of evolution. These include protein glycosylation (ALG3, ALG6, ity at another (Katsanis et al. 2001) . Genetic interaction tests in Drosophila could help clarify the functional B4GALT1, DPM1, FUCT1, GCS1, MGAT2, MPDU1, PMI, PPM2) , as well as signaling pathways, notably the Hedgerelevance of the physical interaction between mammalian ZIC2 and GLI3 proteins (Koyabu et al. 2001) . hog pathway (SHH, PTCH, PTCH2, GLI3, GPC3) and those mediated by small G proteins (ARHGEF6, GDI1, OPHN1, The number of MR genes is very large, but they may be involved in a relatively small number of interconnected PAK3, FGD1, GPH, RSK2, and others).
Given this remarkable conservation of MR genes, we pathways. If so, a modest number of pharmacological treatment strategies might be effective for many MR propose that Drosophila genetics can be used in a systematic manner to study MR. We have selected 42 fly patients. In fact, some types of acquired MR might benefit from the same drugs. Diagnoses of hereditary MR are genes (the orthologs of 43 human MR genes) as "prime candidates" for such analyses (Table 3 ). These genes typically made early in life at a time when developmental brain plasticity provides an opportunity for therapeutic most likely act selectively within the brain during development to establish the anatomical and physiological intervention. The widespread functional conservation of MR genes in Drosophila indicates that this genetic substrates for experience-dependent plasticity. The majority of prime-candidate orthologs currently have fly model system could play a critical role in the discovery of novel treatment strategies for MR. mutants available (about the same fraction as have mouse mutants available) and the rest can be mutagen- tion (e.g., Pak, dfmr1). For a few genes, neuronal defects in the mushroom bodies, an arthropod learning and memory center (Zars 2000) , have been demonstrated The degree to which fly mutant phenotypes "match" 
